...PIK3CA(H1047R) mutation. PIK3CA(H1047R) expression alone failed to promote tumor formation, but dramatically enhanced tu...
...PIK3CA, and TP53, with an overall concordance of 76%. In conclusion, targeted sequencing of plasma ctDNA may be a feasib...
...PIK3CA, and PTEN genes as well as mutations in the receptor tyrosine kinase families. While the increased mutations in B...
...PIK3CA amplification in Japanese patients with non-small-cell lung cancer (NSCLC).,The copy numbers of the seven above-m...
...PIK3CA and CDK6 mutations.,Further investigation on AZD6482 profile revealed that mutations in RB1, KRAS, NRAS and APC c...
...PIK3CA gene activating mutations, with an overall frequency of 20-40%. The aims of our study were to investigate PIK3CA ...
...PIK3CA mutations were infrequently seen. Invasive growth was present in 54% of the cases. Tumor size and Ki-67 index sho...
...PIK3CA (179, 14.3%); 137 (11.0%) cancers had high microsatellite instability (MSI). Women had significantly higher high ...
...PIK3CA/PIK3R1 mutations compared to those with wt-PIK3CA/PIK3R1 or PTEN mutations. For both ARQ 092 and ARQ 751, PIK3CA/...
...PIK3CA, FGFR1, and CCND1 or the pathways of which they are components. However, quantitative differences in everolimus b...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
